Kyle C. Elrod
Chief Operating Officer chez FORTY SEVEN, INC.
Profil
Kyle C.
Elrod is currently a Senior Vice President-Planning & Operations at Forty Seven, Inc. He previously worked as a Director-Program Management at Life Technologies, Inc., a Director-Project Management at Celera Group, a Director-Research & Development Projects at Celera Pharmaceuticals, a Senior Scientist at Axys Pharmaceuticals, Inc., and a Senior Scientist at ARRIS Group, Inc. He also served as Vice President-Project Management & Planning at Virobay, Inc. from 2006 to 2012.
Mr. Elrod received his undergraduate degree from the University of California, Berkeley.
Postes actifs de Kyle C. Elrod
| Sociétés | Poste | Début |
|---|---|---|
| FORTY SEVEN, INC. | Chief Operating Officer | - |
Anciens postes connus de Kyle C. Elrod
| Sociétés | Poste | Fin |
|---|---|---|
Celera Pharmaceuticals
 Celera Pharmaceuticals Pharmaceuticals: MajorHealth Technology Celera Pharmaceuticals manufactures pharmaceutical products. | Corporate Officer/Principal | - |
Life Technologies, Inc.
 Life Technologies, Inc. BiotechnologyHealth Technology Life Technologies, Inc. provides essential technologies needed by the biotechnology and biopharmaceutical communities. The company manufactures and markets a breadth of offerings unique in the industry, used in applications of the life sciences discovery, development, and production process | Corporate Officer/Principal | - |
| ARRIS GROUP INC | Chief Tech/Sci/R&D Officer | - |
Celera Group
 Celera Group Pharmaceuticals: MajorHealth Technology Celera Group provides molecular diagnostics using proprietary genomics and proteomics discovery platforms to identify and validate novel diagnostic markers and to develop diagnostic products based on these markers. These diagnostic products are used to predict disease risk and optimize therapy selection, monitoring and patient outcome. The company was founded in May, 1998 and is located in Rockville, MD | Corporate Officer/Principal | - |
Axys Pharmaceuticals, Inc.
 Axys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Axys Pharmaceuticals, Inc. engages in the development of integrated drugs. The company is headquartered in South San Francisco, CA. | Chief Tech/Sci/R&D Officer | - |
Formation de Kyle C. Elrod
| University of California, Berkeley | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Life Technologies, Inc.
Life Technologies, Inc. BiotechnologyHealth Technology Life Technologies, Inc. provides essential technologies needed by the biotechnology and biopharmaceutical communities. The company manufactures and markets a breadth of offerings unique in the industry, used in applications of the life sciences discovery, development, and production process | Health Technology |
Axys Pharmaceuticals, Inc.
Axys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Axys Pharmaceuticals, Inc. engages in the development of integrated drugs. The company is headquartered in South San Francisco, CA. | Health Technology |
ARRIS Group, Inc.
 ARRIS Group, Inc. Telecommunications EquipmentElectronic Technology ARRIS Group, Inc. operates as a global communications technology firm. It specializes in the design and engineering of broadband networks. The firm's products include video processing and delivery, broadband delivery, access networking, broadband and video devices, and customer experience management. The company was founded in 2001 and is headquartered in DE. | Electronic Technology |
Virobay, Inc.
 Virobay, Inc. Pharmaceuticals: MajorHealth Technology Virobay, Inc. develops protease inhibitors for the treatment of neuropathic pain, cancer, autoimmune and liver diseases. It utilize cysteine cathepsin platform for the development and commercialization of novel drugs. The firm's research & development activities focuses on neuropathic pain, autoimmune diseases and liver fibrosis. The company was founded by Robert F. G. Booth on May 18, 2006 and is headquartered in Menlo Park, CA. | Health Technology |
Celera Group
Celera Group Pharmaceuticals: MajorHealth Technology Celera Group provides molecular diagnostics using proprietary genomics and proteomics discovery platforms to identify and validate novel diagnostic markers and to develop diagnostic products based on these markers. These diagnostic products are used to predict disease risk and optimize therapy selection, monitoring and patient outcome. The company was founded in May, 1998 and is located in Rockville, MD | Health Technology |
Forty Seven, Inc.
 Forty Seven, Inc. Pharmaceuticals: MajorHealth Technology Forty Seven, Inc. develops therapies that target cancer immune evasion pathways. It develops Hu5F9-G4, a monoclonal antibody against human CD47 that potentially has applications spanning multiple tumor types and treatment modalities. The company was founded by Irving L. Weissman, Ravi Majeti, Mark Chao and Jens-Peter Volkmer in 2014 and is headquartered in Menlo Park, CA. | Health Technology |
Celera Pharmaceuticals
Celera Pharmaceuticals Pharmaceuticals: MajorHealth Technology Celera Pharmaceuticals manufactures pharmaceutical products. | Health Technology |
